387974

The motor effects of 0.25% bupivacaine vs 0.19 bupivacaine in ultrasound-guided axillary brachial plexus block in pediatrics undergoing below-elbow orthopedic surgeries: A random

Article

Last updated: 05 Jan 2025

Subjects

-

Tags

-

Abstract

Background
The standard dose of bupivacaine used in axillary brachial plexus block (ABPB) in pediatrics is 0.5 ml/kg of bupivacaine 0.25%. However, bupivacaine (0.19%) is still to be investigated for peripheral nerve block in pediatrics regarding the efficacy and adequacy of intra- and postoperative analgesia and degree of motor affection. We aimed to compare different concentrations (0.25%, 0.19%) of bupivacaine plus dexmedetomidine mixture to perform US-ABPB in pediatrics undergoing upper limb surgery distal to the elbow regarding affecting the postoperative motor power and adequacy of intra- and postoperative analgesia.
Methods
This prospective, randomised-controlled, double-blinded work was performed on 60 pediatric individuals presenting for upper limb orthopedic surgeries in the wrist, hand, and elbow distal to cubital fossa with surgical time planned to not exceed 1 h. 0.25% bupivacaine plus 1 µg/kg dexmedetomidine (Group A) or 0.19% bupivacaine in addition to 1 µg/kg dexmedetomidine (Group B) were given at random to participants. Motor power and pain were assessed using the Modified Bromage scale, Face, Legs, Activity, Cry, and Consolability (FLACC) score, respectively.
Results
A highly substantial variation was recorded between the two groups in Bromage 0 till Bromage 60 with higher values in group (B), and no substantial variation was found in Bromage 90 till Bromage 180 existed between the two groups. No substantial variation existed among the two groups with regard to FLACC score in FLACC0 (immediately after recovery), 1 hour after recovery, and 12 hour after recovery, and FLACC was significantly more ( < 0.05) in group B contrasted to group A in the 4 hour after recovery and 8 hour after recovery.
Conclusion
Using a lower concentration of bupivacaine (0.19%) plus dexmedetomidine (1 µg/kg) was associated with regain of postoperative motor power with the same postoperative analgesic efficacy compared to the standard concentration (0.25%) bupivacaine plus dexmedetomidine (1 µg/kg) in the early postoperative period in US-ABPB.

DOI

TEJA-2023-0194

Keywords

Bupivacaine, Dexmedetomidine, ultrasound-guided axillary block, Pediatrics, below-elbow orthopedic surgeries

Authors

First Name

Abdelmoneim

Last Name

Adel Abdelmoneim

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Sarah

Last Name

Abdelrasoul Hafez

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Maha

Last Name

Gmail Hanna

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

First Name

Dalia Saad

Last Name

Abdel Kader

MiddleName

-

Affiliation

-

Email

-

City

-

Orcid

-

Volume

39

Article Issue

1

Related Issue

51163

Issue Date

2023-12-01

Receive Date

2023-07-31

Publish Date

2023-12-31

Page Start

785

Page End

793

Print ISSN

1110-1849

Online ISSN

1687-1804

Link

https://egja.journals.ekb.eg/article_387974.html

Detail API

https://egja.journals.ekb.eg/service?article_code=387974

Order

387,974

Publication Type

Journal

Publication Title

Egyptian Journal of Anaesthesia

Publication Link

https://egja.journals.ekb.eg/

MainTitle

The motor effects of 0.25% bupivacaine vs 0.19 bupivacaine in ultrasound-guided axillary brachial plexus block in pediatrics undergoing below-elbow orthopedic surgeries: A random

Details

Type

Article

Created At

21 Dec 2024